News | October 02, 2006

ICDs Benefit Dialysis Patients

A retrospective study at Northwestern University Feinberg School of Medicine, Chicago, showed that dialysis patients who had implantable cardiac defibrillator (ICD) therapy were more likely to receive appropriate shocks for ventricular tachycardia or ventricular fibrillation — but they also had worse survival compared with a nondialysis cohort, according to Medscape Medical News.

"Being on dialysis was the greatest predictor of using the device for a particular tachyarrhythmia. However, even though these devices were in place and were being used [appropriately], dialysis patients still had a survival significantly less than patients without dialysis,” said study author Dr. Rod S. Passman. “In a sense, this is not terribly surprising, because we know that dialysis patients have a lot of competing comorbidities and that perhaps decreasing the risk of sudden death with a defibrillator still leaves them open to dying from other diseases."

Because it was a retrospective study with inherent study design biases, Dr. Passman added, it could not answer the question of whether defibrillators can actually prolong life in dialysis patients.

The study will appear in the October 2006 issue of Heart Rhythm.

Related Content

ICD Placements Not Meeting Medicare Coverage Criteria Decline After Overuse Investigation Announced
Feature | Implantable Cardioverter Defibrillator (ICD) | July 11, 2018
Placement of implantable cardioverter defibrillators (ICDs) not meeting Centers for Medicare and Medicaid Services (CMS...
New Tool Predicts Benefits and Risks of Implantable Defibrillator for Heart Failure Patients
News | Implantable Cardioverter Defibrillator (ICD) | July 02, 2018
University of Washington (UW) Medicine cardiologists have developed a tool to predict which heart-failure patients...
Real-World Data Demonstrates Success Of Smart Pass Filter on Boston Scientific S-ICD System
News | Implantable Cardioverter Defibrillator (ICD) | May 16, 2018
Boston Scientific announced results from an analysis of the LATITUDE database evaluating the successful reduction of...
Online Message Board Advice on ICDs Reflects Inaccuracies
News | Implantable Cardioverter Defibrillator (ICD) | April 13, 2018
April 13, 2018 — Medical advice about implanted cardiac defibrillators obtained via an online message board appears t
Biotronik U.S. to Distribute Aziyo ECM Envelopes
News | Implantable Cardioverter Defibrillator (ICD) | April 12, 2018
Biotronik U.S. and Aziyo announced a strategic agreement allowing Biotronik to distribute Aziyo's CanGaroo...
Boston Scientific Launches Resonate Devices With HeartLogic Heart Failure Diagnostic
Technology | Implantable Cardioverter Defibrillator (ICD) | September 27, 2017
September 27, 2017 — Boston Scientific recently launched the Resonate family of...
Abbott Secures FDA Approval for MRI Compatibility on Ellipse ICD
Technology | Implantable Cardioverter Defibrillator (ICD) | September 22, 2017
Abbott announced U.S. Food and Drug Administration (FDA) approval for magnetic resonance (MR)-conditional labeling for...
Predictive Models May Help Determine Which Patients Benefit From ICDs
News | Implantable Cardioverter Defibrillator (ICD) | July 06, 2017
Two predictive models may help cardiologists decide which patients would most benefit from an implantable cardioverter...
Videos | Implantable Cardioverter Defibrillator (ICD) | June 01, 2017
Lucas Boersma, M.D., Ph.D., FESC, St.
Overlay Init